Aflibercept 8mg in Patients with Neovascular Age Related Macular Deg…

Jean-Francois Korobelnik

AAO 2024 Insights: Anterior Vitrectomy

AAO 2024 Insights

T. Oetting

AAO 2024 Insights: Surgical Retina Myth - Pneumatic Retinopexy is In…

AAO 2024 Insights

R. Muni

RETINA: Ethics and Retinal Issues in Elderly: Case Presentation and …

Houston Methodist

G. Davis

AAO 2024 Insights: Pneumatic Retinopexy

AAO 2024 Insights

R. Muni

Radiation Retinopathy

Arun Singh

AAO 2024 Insights: Imaging Biomarkers for Post-Retinal Detachment Su…

AAO 2024 Insights

A. Rachitskaya

AAO 2024 Insights: Update on the Management Options for Sickle Cell …

AAO 2024 Insights

J. Lim

The Effect of Fenofibrate on Progression of Diabetic Retinopathy: th…

ADA 2024 Insights

D. Preiss

AAO 2024 Insights: Management of Floaters

AAO 2024 Insights

J. Kitchens

Challenges in Managing ROP in the Evolving Neonatal Landscape

AAO 2023

M. Hartnett

AAO 2024 Insights: Uveal Melanoma - Precursors and New Drugs

AAO 2024 Insights

C. L. Shields

AAO 2024 Insights: Macular Atrophy in the Anti-VEGF Era

AAO 2024 Insights

B. Blodi

AAO 2024 Insights: Drugs in the Pipeline for Diabetic Eye Disease

AAO 2024 Insights

D. Boyer

AAO 2024 Insights: Aflibercept 8 mg for Diabetic Macular Edema - Wee…

AAO 2024 Insights

S. Adrean

Evaluation and Review of Automated Diabetic Retinopathy Screening

AAO 2023

R. Channa

Overview and Novel Approaches to Central Serous Retinopathy

AAO 2023

M. Singer

Internal Limiting Membrane Flap: Advantages and Techniques

Zofia Nawrocka

Wet AMD What is in the Pipeline in 2024

Keck School of Medicine of USC

D. Boyer

How Best to Follow Geographic Atrophy Patients Receiving Anti-Comple…

Karl Csaky